Academic Press Therapeutic Potentials of Tenofovir Alafenamide in Hepatitis B

Therapeutic Potentials of Tenofovir Alafenamide in Hepatitis B offers a comprehensive examination of the therapeutic potentials of Tenofovir Alafenamide (TAF) in hepatitis B, providing a succinct and up-to-date summary of all relevant evidence for this first-line oral antiviral agent. The text delves into key topics such as the pharmacological profile of TAF, its comparative efficacy against traditional antiviral agents, safety and tolerability, and the impact of TAF on drug resistance. Additionally, it explores the use of TAF in special populations, including pediatrics, the elderly, and individuals with renal impairment, as well as future directions in hepatitis B treatment strategies. Readers will discover the diverse potential applications of TAF in chronic hepatitis B, informed by valuable lessons learned from HIV treatment while also gaining insights into future therapeutic possibilities. Authored by leading experts in the field, each chapter presents focused and insightful perspectives, making this book an indispensable resource for practitioners and researchers alike. Serving as a critical resource for physicians, researchers, pharmacologists, and biomedical scientists, this book highlights the core knowledge necessary for understanding TAF and its clinical applications. Provides a comprehensive and up-to-date summary of all relevant evidence for Tenofovir Alafenamide (TAF), a leading oral antiviral agent for hepatitis B Presents an exploration of the diverse potential indications for Tenofovir Alafenamide in chronic hepatitis B that is informed by valuable lessons learned from HIV infection management Authored by prominent leaders in the field of chronic hepatitis B who offer expert insights and perspectives that enhance the depth and credibility of the content